Investigating resistance of glioblastoma multiforme to radiotherapy and chemotherapy
<p>Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumour. Despite treatment with surgery, radiotherapy and temozolomide (TMZ) chemotherapy, patient survival remains poor, suggesting that GBM cells evade and resist these therapies. The insulin-like growth factor 1...
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | |
| التنسيق: | أطروحة |
| اللغة: | English |
| منشور في: |
2016
|
| الموضوعات: |